SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001213900-20-000667
Filing Date
2020-01-09
Accepted
2020-01-09 17:12:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 8112
2 PRELIMINARY OFFERING CIRCULAR f1a2019a1_amarantusbio.htm PART II AND III 1211742
3 OPINION OF EILERS LAW GROUP, P.A. REGARDING LEGALITY OF THE SECURITIES COVERED I f1a2019a1ex12-1_amarantusbio.htm EX1A-12 OPN CNSL 8714
4 GRAPHIC image_001.jpg GRAPHIC 7098
  Complete submission text file 0001213900-20-000667.txt   1239890
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11084 | Film No.: 20518787
SIC: 2834 Pharmaceutical Preparations